Colgate-Palmolive (CL) Expected to Announce Earnings on Friday

Colgate-Palmolive (NYSE:CLGet Free Report) is anticipated to release its Q3 2025 results before the market opens on Friday, October 31st. Analysts expect Colgate-Palmolive to post earnings of $0.91 per share and revenue of $5.1707 billion for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Friday, October 31, 2025 at 8:30 AM ET.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.91 earnings per share. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Colgate-Palmolive Stock Performance

CL stock opened at $75.61 on Thursday. The company has a market capitalization of $61.11 billion, a P/E ratio of 21.24, a PEG ratio of 4.53 and a beta of 0.34. The company has a 50-day simple moving average of $80.82 and a 200 day simple moving average of $86.58. Colgate-Palmolive has a fifty-two week low of $75.38 and a fifty-two week high of $100.18. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.8%. Colgate-Palmolive’s payout ratio is 58.43%.

Hedge Funds Weigh In On Colgate-Palmolive

A number of hedge funds have recently added to or reduced their stakes in CL. Beck Mack & Oliver LLC acquired a new position in Colgate-Palmolive during the second quarter valued at approximately $206,000. MUFG Securities EMEA plc acquired a new position in Colgate-Palmolive during the second quarter valued at approximately $217,000. Financial Advisors Network Inc. acquired a new position in Colgate-Palmolive during the second quarter valued at approximately $245,000. State of Wyoming grew its holdings in Colgate-Palmolive by 39.5% during the second quarter. State of Wyoming now owns 3,894 shares of the company’s stock valued at $354,000 after purchasing an additional 1,102 shares during the last quarter. Finally, Main Street Financial Solutions LLC grew its holdings in Colgate-Palmolive by 3.7% during the second quarter. Main Street Financial Solutions LLC now owns 4,233 shares of the company’s stock valued at $385,000 after purchasing an additional 151 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. The Goldman Sachs Group dropped their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, October 2nd. Raymond James Financial cut their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on Colgate-Palmolive in a report on Friday, October 10th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. Finally, Bank of America cut their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $91.50.

Check Out Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Earnings History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.